Tumor-suppressive function and mechanism of HOXB13 in right-sided colon cancer
Open Access
- 29 November 2019
- journal article
- research article
- Published by Springer Science and Business Media LLC in Signal Transduction and Targeted Therapy
- Vol. 4 (1), 1-14
- https://doi.org/10.1038/s41392-019-0086-1
Abstract
Right-sided colon cancer (RCC) and left-sided colon cancer (LCC) differ in their clinical and molecular features. An investigation of differentially expressed genes (DEGs) between RCC and LCC could contribute to targeted therapy for colon cancer, especially RCC, which has a poor prognosis. Here, we identified HOXB13, which was significantly less expressed in RCC than in LCC and associated with prognosis in RCC, by using 5 datasets from the Gene Expression Omnibus (GEO). Tissue sample analysis showed that HOXB13 was differentially expressed between normal and only RCC tumor tissues. HOXB13 inhibited colon cancer cell proliferation and induced apoptosis both in vitro and in vivo. Furthermore, we found that HOXB13 might be regulated by DNMT3B and suppress C-myc expression to exert antitumor effects via β-catenin/TCF4 signals in RCC. In conclusion, the current study is the first to demonstrate that HOXB13 has a tumor-suppressive effect in RCC. High expression levels of HOXB13 are associated with prolonged overall survival in patients with RCC. The DNMT3B-HOXB13-C-myc signaling axis might be a molecular target for the treatment of RCC.Keywords
Funding Information
- National Natural Science Foundation of China (81572592)
- The Ten thousand plan youth talent support program of Zhejiang Province. The Zhejiang medical innovative discipline construction project-2016.
This publication has 44 references indexed in Scilit:
- ATRA Inhibits the Proliferation of DU145 Prostate Cancer Cells through Reducing the Methylation Level of HOXB13 GenePLOS ONE, 2012
- Novel Functional MAR Elements of Double Minute Chromosomes in Human Ovarian Cells Capable of Enhancing Gene ExpressionPLOS ONE, 2012
- Germline Mutations inHOXB13and Prostate-Cancer RiskNew England Journal of Medicine, 2012
- Gene Expression Differences between Colon and Rectum TumorsClinical Cancer Research, 2011
- HOXB13, a Target of DNMT3B, Is Methylated at an Upstream CpG Island, and Functions as a Tumor Suppressor in Primary Colorectal TumorsPLOS ONE, 2010
- The landscape of somatic copy-number alteration across human cancersNature, 2010
- RETRACTED: A New Class of Quinoline-Based DNA Hypomethylating Agents Reactivates Tumor Suppressor Genes by Blocking DNA Methyltransferase 1 Activity and Inducing Its DegradationCancer Research, 2009
- Hypermethylator Phenotype in Sporadic Colon Cancer: Study on a Population-Based Series of 582 CasesCancer Research, 2008
- Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoidGut, 2005
- DNMT1 and DNMT3b cooperate to silence genes in human cancer cellsNature, 2002